Value proposition

We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based platform, delivers actionable insights into therapies to our pharmaceutical and biotech partners.

Oncimmune’s ImmunoINSIGHTS platform enables life-science organisations to optimise drug development and delivery, leading to more effective targeted as well as safer treatments for patients.

Oncimmune is headquartered in the UK, with a discovery research centre in Dortmund, Germany and an office in Cambridge MA, USA.

Lung cancer, Autoantibodies, Immuno oncology, Immunotherapy, Autoimmune Disease, Cancer, Infectious disease, COVID-19, Systemic Lupus, Systemic Sclerosis, Companion diagnostics, and Bioinformatics